|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT02195076 |
|
Date of registration:
|
16/07/2014 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Non Invasive Detection of Lung and Breast Cancer by Odor Signature
|
|
Scientific title:
|
A Clinical Study Design to Evaluate the Specificity and Sensitivity of Our Novel System for Detection of Breast and Lung Cancer by Odor Signature |
|
Date of first enrolment:
|
July 2014 |
|
Target sample size:
|
400 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT02195076 |
|
Study type:
|
Observational [Patient Registry] |
|
Study design:
|
Observational Model: Case Control, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Israel
| | | | | | | |
|
Contacts
|
|
Name:
|
Einav Gal-Yam, MD PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
Einav.NiliGal-Yam@sheba.health.gov.il |
|
Affiliation:
|
|
|
|
Name:
|
Michal Mark Danieli, PhD |
|
Address:
|
|
|
Telephone:
|
+972-4-7706816 |
|
Email:
|
Michal@biosensem.com |
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Diagnosed Lung Cancer patients
- Diagnosed Breast Cancer patients
Exclusion Criteria:
- Cancer patients who were treated using chemotherapy
- Cancer patients who were treated using radiation
- Cancer patients who were treated using biological treatments
- Cancer patients who were treated with chemotherapy
- Cancer patients who were treated with any anti- cancer therapies
- Cancer patients who use drugs that affect the immune system
Age minimum:
30 Years
Age maximum:
80 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Breast Cancer
|
|
Lung Cancer
|
|
Intervention(s)
|
|
Other: non-invasive detection of cancer odor
|
|
Primary Outcome(s)
|
|
The sensitivity and specificity of our biosensors in lung and breast cancer detection
[Time Frame: 3 years]
|
|
Secondary Outcome(s)
|
|
Testing the ability of our biosensors to distinguish between different sub- types of breast and lung cancer.
[Time Frame: 3 years]
|
|
Secondary ID(s)
|
|
0695-13-SMC
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|